FemSoft Consumer, Physician Ad Campaign Planned By Rochester Medical
This article was originally published in The Gray Sheet
Executive Summary
Rochester Medical's marketing strategy for the FemSoft insert for treatment of female stress urinary incontinence will include campaigns aimed at both physicians and consumers.
You may also be interested in...
Rochester Medical FemSoft Incontinence Insert Among FY 1999's 33 PMAs
FDA approval of Rochester Medical's FemSoft insert for female stress urinary incontinence on Sept. 30, the final day of the federal government's fiscal year, apparently put the agency's total number of approved, original premarket approval applications for the year at 33, down from 42 in 1998 and 46 in 1997.
Amunix Raises $117m To Take Novel T-Cell Engager Into The Clinic
Amunix’s XTEN technology for half-life extension and precise drug delivery has been used by multiple partners over the past 15 years, but now the firm is building its own cancer therapy pipeline.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: